The Valley Desk

NCT03301220 · Interventional trial

A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

Overall registry status Completed

Phase 3

Conditions Smoldering Multiple Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov